An interventional study of Oral Nutrition Supplement in Diabetes Mellitus, Type 2, sponsored by Société des Produits Nestlé (SPN). Completed at 1 site in United States. Open to participants aged 20 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-11-19.
Sponsored by Société des Produits Nestlé (SPN) · Not applicable, Interventional, and Supportive care
This will be a randomized crossover design. The subjects will be randomized to one of six interventions on six separate study days, one week apart.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,318 are open to participants now.
This study's enrollment of 14 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Société des Produits Nestlé (SPN) is the lead sponsor of 314 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subject inclusion criteria
All subjects must comply with all the following inclusion criteria:
Subject exclusion criteria Subjects representing one or more of the following criteria are excluded from participation in the study.
Product containing calories from carbohydrate, protein, and fat
Other: Oral Nutrition Supplement
Product containing calories from carbohydrate, protein, and fat
Other: Oral Nutrition Supplement
Product containing calories from carbohydrate, protein, and fat
Other: Oral Nutrition Supplement
Product containing calories from carbohydrate, protein, and fat
Other: Oral Nutrition Supplement
Product containing calories from carbohydrate, protein, and fat
Other: Oral Nutrition Supplement
Product containing calories from carbohydrate, protein, and fat
Other: Oral Nutrition Supplement
Product intake of oral nutrition supplement provided
Area under the blood glucose curve (ACU 0-240 minutes)
Time frame: Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
Area under the insulin curves (AUC 0-240)
Time frame: Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
Insulinogenic index [Change in Ins30/Change in Glu30]
Time frame: [Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes]
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Société des Produits Nestlé (SPN)